Well considering PJT asks a ton of Rx questions whilst the others don't, I'd say that makes PJT harder

 

Got asked like 4 pretty basic rx questions in both round 1 and ac. Wasted time Over-preparing for the rx portion cause of pjt hypers like you when all I had to do was skim the first few pages of the rx guide. Moelis asked rx questions too that were just as basic, and considering evercore and gs were both for pure advisory there was obviously no rx content assessed but were more difficult in their own respect.

 

My technical questions were half restructuring and some of the questions were complex. My point that asking Rx questions makes it harder is that there is a bunch of extra content to learn, making it harder than m&a interviews as everyone has already learned the content for that.

Not sure why you're MSing when I'm just giving an account of my experiences.

 
Most Helpful

I am a eu student, and all my school friends got asked very similar questions, with 2 of my friends in the uk getting asked very similar questions between themselves too. This means that I know that your interviews were probably similar to my uk friends and there's was not that bad. I know because they made eu students questions harder than domestic and I still didn't find it that difficult. Yes there is more content to learn, but it isn't really difficult stuff for the summer analyst, off cycle and full time much worse. I think you are just new to rx stuff so you find it weird. Once you've read a bit into it (more than just rxinterviews.com lol atleast get the guides), you will see the top difficulty of these questions can be just as bad as the top difficulty of some m&a questions (e.g. advanced merger model, which I was asked in gs). I chose gs, but I liked pjt process since it was pretty quick, not too time consuming. evercore taken my fuck time away man and they do same process for ft as sa (I was going for ft for evercore but sa for gs) so I know the sa had tough time.

 

Optio ut voluptatibus et praesentium. Et voluptatem dolorem nihil placeat qui. Omnis facere sit magni adipisci totam autem.

Qui commodi ipsum sit non et ipsam incidunt. Dicta et qui qui exercitationem et eaque laboriosam. Distinctio dolores id iure.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Lazard Freres No 98.8%
  • Harris Williams & Co. 25 98.3%
  • Goldman Sachs 17 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”